Astrazeneca Plc Net Income per Employee (AZN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Astrazeneca Plc  (NASDAQ: AZN)
 

Astrazeneca Plc Net Income per Employee

AZN's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 45.33% in the fourth quarter 2025, year on year to cumulative value of $12,681 million, and with 83,100 employees, Astrazeneca Plc's income per employee grew on trailing twelve month basis to $ 152,599, this is below the company average income per employee.
The Healthcare sector has seen employees of 51 other companies achieving higher income per employee. While Astrazeneca Plc's total ranking has deteriorated compared to the previous quarter from 0 to 1048.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AZN Net Income per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Net Income Change 45.33 % - 26.97 % - 18.12 %
Net Income per Employee (TTM) $ 152,599 114,188 114,188 107,930 107,930
AZN's Total Ranking # 1048 # 0 # # #
Seq. Net Income Change - - - - -

AZN Company Profile >> Back to AZN Efficiency Comparisons >> Compare AZN Net Income per Employee to its Competitors

AZN Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 52
Healthcare Sector # 86
Overall Market # 1048

Net Income per Employee Statistics
High Average Low
$ 123,141 $ 52,802 $ 1,384
(Dec 31 2025)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025
Dariohealth Corp   252,812.12 $ 41.714  Million 165 
Vaxart Inc   251,184.62 $ 16.327  Million 65 
Merck and Co Inc   243,506.67 $ 18,263.000  Million 75,000 
Interpace Biosciences Inc   240,931.37 $ 24.575  Million 102 
Ironwood Pharmaceuticals inc   240,170.00 $ 24.017  Million 100 
Neurocrine Biosciences Inc   239,300.00 $ 478.600  Million 2,000 
Adma Biologics Inc   227,094.28 $ 146.930  Million 647 
Community Health Systems Inc   218,064.52 $ 676.000  Million 3,100 
Bristol myers Squibb Company  217,076.92 $ 7,055.000  Million 32,500 
Transmedics Group Inc   211,905.35 $ 190.291  Million 898 
Indivior Pharmaceuticals Inc   210,000.00 $ 210.000  Million 1,000 
Lantheus Holdings Inc   195,774.52 $ 233.559  Million 1,193 
Johnson and Johnson  190,369.32 $ 26,804.000  Million 140,800 
Novartis Ag  185,566.05 $ 13,967.000  Million 75,267 
Zoetis Inc   184,344.83 $ 2,673.000  Million 14,500 
Grifols Sa  174,291.94 $ 560.000  Million 3,213 
Puma Biotechnology Inc   173,804.47 $ 31.111  Million 179 
Biogen Inc   172,386.67 $ 1,292.900  Million 7,500 
Intuitive Surgical Inc   169,003.00 $ 2,876.600  Million 17,021 
Kiniksa Pharmaceuticals International Plc  161,215.85 $ 59.005  Million 366 
Sab Biotherapeutics Inc   154,345.15 $ 13.274  Million 86 
Collegium Pharmaceutical Inc   148,628.84 $ 62.870  Million 423 
Iradimed Corporation  135,421.69 $ 22.480  Million 166 
Corcept Therapeutics Inc  134,480.82 $ 98.171  Million 730 
Resmed Inc   130,683.82 $ 1,485.875  Million 11,370 
Carlisle Companies Incorporated  125,542.37 $ 740.700  Million 5,900 
Alnylam Pharmaceuticals Inc   125,498.80 $ 313.747  Million 2,500 
Astrazeneca Plc  123,140.79 $ 10,233.000  Million 83,100 
Alkermes Plc   117,884.88 $ 241.664  Million 2,050 
Soleno Therapeutics Inc  114,780.22 $ 20.890  Million 182 


Date modified: 2026-07-07T09:23:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.